))
KL-50 in post TMZ MMR-deficient GBM
Manage episode 506019507 series 3689588
Content provided by Neuro-Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Neuro-Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
107 episodes
Share
